The effects, albeit in the bum, are similar to those who've battled 'Ozempic face' with the rapid weight loss leaving some users looking ill, exacerbating wrinkles and causing skin to sag
Semaglutide is a GLP-1 receptor agonist a medication that mimics glucagon-like peptide-1, a gut hormone your body naturally releases after eating
In Eli Lilly's pivotal Phase 3 ATTAIN clinical trialsthe studies that led to FDA approvalparticipants taking orforglipron achieved average body weight reductions of approximately 7.9% to 8.7% over 36 to 40 weeks, depending on the dosing
Further studies are needed to confirm the actual benefit of this molecule on metabolic liver diseases and define the best route of administration and the most appropriate dosage, allowing its use in clinical practice
With the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, it exhibits stability against enzymatic degradation and gastric acidity